We are live on ! Find out more
FDCC

Foster Dykema Cabot & Co Portfolio holdings

AUM $827M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
-2.47%
1 Year Est. Return
+18.87%
3 Year Est. Return
+34.03%
5 Year Est. Return
+67.09%
10 Year Est. Return
+162.67%
AUM
$796M
AUM Growth
-$14.5M
Cap. Flow
+$7.33M
Cap. Flow %
0.92%
Top 10 Hldgs %
68.03%
Holding
114
New
8
Increased
17
Reduced
28
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 8.61%
2 Financials 7.22%
3 Healthcare 6.72%
4 Industrials 4.56%
5 Consumer Discretionary 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPST icon
1
JPMorgan Ultra-Short Income ETF
JPST
$39.8B
$198M 24.9%
3,952,216
+28,034
+0.7% +$1.41M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$143M 18%
401,162
+3,124
+0.8% +$1.24M
ICSH icon
3
iShares Ultra Short Duration Bond Active ETF
ICSH
$7.85B
$60M 7.54%
1,200,254
+32,615
+3% +$1.63M
COST icon
4
Costco
COST
$417B
$22.4M 2.81%
47,386
+91
+0.2% +$47.3K
TMO icon
5
Thermo Fisher Scientific
TMO
$198B
$21.5M 2.69%
42,299
+86
+0.2% +$48.1K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$21.2M 2.66%
79,379
-22
-0% -$6.26K
APH icon
7
Amphenol
APH
$186B
$20.9M 2.62%
623,576
+1,818
+0.3% +$66K
AMZN icon
8
Amazon
AMZN
$2.66T
$19M 2.39%
168,254
+394
+0.2% +$49.8K
MSFT icon
9
Microsoft
MSFT
$2.93T
$18.8M 2.36%
80,559
+404
+0.5% +$107K
AXP icon
10
American Express
AXP
$242B
$16.4M 2.06%
121,604
-38,370
-24% -$5.81M
XLI icon
11
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$15.6M 1.96%
188,292
+971
+0.5% +$89.4K
IEFA icon
12
iShares Core MSCI EAFE ETF
IEFA
$186B
$15.3M 1.92%
290,642
-556,616
-66% -$32.7M
ACN icon
13
Accenture
ACN
$87.9B
$15.1M 1.9%
58,671
+201
+0.3% +$58.1K
JPM icon
14
JPMorgan Chase
JPM
$907B
$14.8M 1.86%
141,457
-15,810
-10% -$1.81M
PLD icon
15
Prologis
PLD
$140B
$14.2M 1.78%
139,675
+796
+0.6% +$98.7K
LLY icon
16
Eli Lilly
LLY
$1.05T
$14M 1.76%
43,331
+40,278
+1,319% +$12.8M
LOW icon
17
Lowe's Companies
LOW
$117B
$13.4M 1.68%
71,386
-31,384
-31% -$6.11M
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$123B
$12.7M 1.6%
+43,891
New +$12.6M
AAPL icon
19
Apple
AAPL
$4.9T
$12.3M 1.55%
89,116
-800
-0.9% -$126K
XLV icon
20
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$11.9M 1.5%
+98,440
New +$12.7M
NOC icon
21
Northrop Grumman
NOC
$74.1B
$11.8M 1.48%
+25,099
New +$12M
XLF icon
22
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$11.8M 1.48%
388,274
-137,591
-26% -$4.55M
VTI icon
23
Vanguard Total Stock Market ETF
VTI
$658B
$11.8M 1.48%
65,599
-1,260
-2% -$251K
WM icon
24
Waste Management
WM
$96.1B
$11.6M 1.46%
+72,390
New +$11.9M
PWR icon
25
Quanta Services
PWR
$94.3B
$11.1M 1.39%
+87,140
New +$11.9M

Similar funds

Foster Dykema Cabot & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Foster Dykema Cabot & Co held 114 positions worth $796M, down 1.8% from $811M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Foster Dykema Cabot & Co's Q3 2022 filing shows 8 new, 17 increased, 28 reduced and 9 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 98,440 shares worth $11.9M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

  • Foster Dykema Cabot & Co's largest Q3 2022 buy was State Street Health Care Select Sector SPDR ETF: 98,440 shares worth $11.9M.
  • Foster Dykema Cabot & Co added most to Eli Lilly in Q3 2022, an estimated $12.8M increase.
  • Foster Dykema Cabot & Co's biggest Q3 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $32.7M.
  • Foster Dykema Cabot & Co fully exited Heliogen, Inc. in Q3 2022, selling an estimated $1.58M.
  • Foster Dykema Cabot & Co's ten largest holdings make up 68% of its $796M portfolio in Q3 2022.
  • Foster Dykema Cabot & Co opened 8 new positions and closed 9 in Q3 2022.
  • Foster Dykema Cabot & Co's portfolio value fell 1.8% quarter-over-quarter to $796M.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2022, filed 20 Oct 2022.